, Tracking Stock Market Picks
Enter Symbol:
MELA Sciences Inc (MELA) [hlAlert]

up 5,830.43 %

MELA Sciences Inc (MELA) rated Sell by BioLogic Equity Research

Posted on: Friday,  Sep 10, 2010  8:25 AM ET by BioLogic Equity Research

BioLogic Equity Research rated Sell MELA Sciences Inc (NASDAQ: MELA) on 09/10/2010, when the stock price was $68.20.
Since then, MELA Sciences Inc has lost 98.31% as of 08/27/2015's recent price of $1.15.
If you would have followed this BioLogic Equity Research's recommendation on MELA, you would have gained 5830.43% of your investment in 1812 days.

Electro-Optical Sciences, Inc. (EOS) is a medical device company focused on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. EOS's flagship product, MelaFind, features a hand-held imaging device that emits light of multiple wavelengths to capture images of suspicious pigmented skin lesions and extract data. The data is then analyzed against EOS's database of melanomas and benign lesions using its algorithms in order to provide information to the physician and produce a recommendation of whether the lesion should be biopsied.

BioLogic Equity Research is an equity research firm. It focuses its research on healthcare sector including biotechnology, pharmaceuticals, and medical technology. The firm offers event-driven research with a focus on regulatory action dates; new product launches; clinical data releases; and long and short-selling opportunities. It researches early to mid-stage companies and basis the stock selection on high-alpha binary events. The firm employs fundamental analysis to conduct its research. It also provides consulting services. The firm caters to institutional investors. It was formerly known as BioLogic Investment Research LLC. BioLogic Equity Research LLC is based in Delray Beach, Florida.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/10/2010 8:25 AM Sell
as of 12/31/2010
1 Week down  -0.97 %
1 Month up  12.35 %
3 Months up  52.14 %
1 YTD up  54.25 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy